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Extracellular adenosine 50 triphosphate (ATP) is a widespread cell-to-cell signaling molecule in the brain,
where it activates cell surface P2X and P2Y receptors. P2X receptors define a protein family unlike other
neurotransmitter-gated ion channels in terms of sequence, subunit topology, assembly, and architecture.
Within milliseconds of binding ATP, they catalyze the opening of a cation-selective pore. However, recent
data show that P2X receptors often underlie neuromodulatory responses on slower time scales of seconds
or longer. Herein, we review these findings at molecular, cellular and systems levels. We propose that, while
P2X receptors are fast ligand-gated cation channels, they aremost adept atmediating slow neuromodulatory
functions that are more widespread and more physiologically utilized than fast ATP synaptic transmission in
the CNS.The Discovery of ATP Signaling
The field of ATP signaling has taken nearly a century to evolve
since the discovery of ATP in 1929 (Khakh and Burnstock,
2009). The first evidence for the release of ATP from sensory
nerves was provided by Pamela Holton in the 1950s (Holton
and Holton, 1954; Holton, 1959). In 1972, Geoffrey Burnstock
proposed the existence of ‘‘purinergic nerves’’ (Burnstock,
1972), laying the foundations of a new field. Forty years later,
there is little doubt that extracellular ATP signaling is widely
utilized in cell sensing.
Much of the early data on purinergic nerves derived from
physiological experiments on smooth muscle preparations. By
the early 1990s, however, ATP was also shown to depolarize
neurons (Jahr and Jessell, 1983; Krishtal et al., 1983), to open
single ion channels in patches of membrane (Benham and Tsien,
1987; Kolb and Wakelam, 1983) and to mediate fast synaptic
transmission at synapses in the peripheral and central nervous
systems (Edwards et al., 1992; Evans et al., 1992; Silinsky
et al., 1992). By this time, ATP receptors had also been subdi-
vided as belonging to two major families: metabotropic P2Y
receptors and ionotropic P2X receptors. With the subsequent
cloning of the genes encoding P2X receptors came a new era.
In this review, we focus on P2X receptor mediated ATP signaling
in the brain, discussing general themes pertinent to mechanisms
and neuromodulation at the molecular, cellular, systems and
disease levels.
Cell Surface Receptors for ATP and Its Metabolites
ATP activates a family of metabotropic P2Y and ionotropic P2X
receptors. Collectively, the actions of ATP and its breakdown
products produce responses that last from milliseconds to
minutes, and even longer time scales through changes in gene
regulation via second messengers. Signaling diversity is further
increased by the fact that ATP receptors display a very broad
range of ATP sensitivities, ranging from nanomolar in the caseof P2Y receptors, to hundreds of micromolar for P2X7 receptors
(Surprenant et al., 1996). Thus, ATP receptors respond over
remarkably broad spatiotemporal scales, and ATP signaling is
very dynamic.
The first P2X receptor genes were identified in 1994 (Brake
et al., 1994; Valera et al., 1994) and within 2 years the whole
family had been identified (Buell et al., 1996; Chen et al., 1995;
Collo et al., 1996; Leˆ et al., 1997; Lewis et al., 1995; Soto et al.,
1996; Surprenant et al., 1996). This was an exciting period that
culminated with the realization that P2X receptors defined
a unique protein family. Each of the homomeric P2X receptors
also displays distinct functional properties (Figure 1; Table 1).
The available data on the subunit composition and properties
of heteromeric P2X receptors (Coddou et al., 2011) are not
considered in depth here.
P2X receptors are nonselective cation channels with high Ca2+
permeability that carry a depolarizing current under standard
physiological conditions. In some cells, P2X channels are also
significantly permeable to anions. For example, the full length
P2X5 receptor is permeable to Cl (North, 2002). This remains
the exception rather than the rule. Thus at its most fundamental
level, P2X receptor mediated neuromodulation starts with
chemistry: ATP rapidly gates P2X receptor pores, triggering
transmembrane fluxes of selected ions.
The seven mammalian P2X subunits range from 379 (P2X6)
to 595 (P2X7) amino acids in length. Each subunit contains
two hydrophobic membrane-spanning segments (TM1 and
TM2) separated by an ectodomain which contains ten con-
served cysteine residues that form disulfide bonds. Represent-
ing the simplest known architecture for ligand-gated ion
channels, P2X receptors adopt a relatively simple fold, with
intracellular N and C termini and most of the molecule forming
an extracellular loop. Multiple lines of evidence have estab-
lished that the channels are trimeric (Barrera et al., 2005; Nicke
et al., 1998; Stoop et al., 1999). This contrasts with eukaryoticNeuron 76, October 4, 2012 ª2012 Elsevier Inc. 51
Figure 1. Fast (Top) and Slow (Bottom)
Desensitization Is Compared for Functional
Recombinant Homomeric Rat P2X
Receptors Expressed in HEK293 Cells
Note the 10-fold difference in time scale between
top and bottom panels. Fast desensitization is
observed only with P2X1 and P2X3 during brief
applications (2 s duration) of ATP (30 mM, except
1 mM for P2X7 owing to its lower sensitivity, see
Table 1). Slow desensitization is observed for
P2X2 and P2X4 with more prolonged applications
(60 s duration) of ATP (30 mM, except 1 mM for
P2X7). In all cases except P2X7, the response
shown is that seen for the first application of ATP
to that cell. For P2X7, one 2min application of ATP
had been made before the application shown.
Note that the rising phase of the response re-
corded for P2X7 receptors is biphasic. This likely
reflects pore dilation associated with the second
slower phase (discussed in the text; see also
Figure 4). The experiments were performed by Dr.
A. Surprenant and the figure is reproduced here
from North (2002) with the author’s permission.
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and with the large family of pentameric ‘‘Cys-loop’’ receptors
(Figure 2) which includes members gated by acetylcholine,
glycine, g-aminobutyric acid, 5-hydroxytryptamine and glutamic
acid. TM1 and TM2 both contribute to the function of the P2X
pore, but the major pore lining segment is TM2 (Egan et al.,
1998; Haines et al., 2001; Jiang et al., 2001; Kracun et al., 2010;
Li et al., 2008; Rassendren et al., 1997; Samways et al., 2008).
Molecular Mechanisms
Flukes, Fins, and Beaks
The crystal structure of the zebrafish P2X4 receptor has provided
a detailed picture of the atomic anatomy of the receptor (Fig-
ure 3A; Hattori and Gouaux, 2012; Kawate et al., 2009). In overall
shape, a single P2X receptor subunit resembles a dolphin rising
from the ocean surface (the cell membrane). The narrow distal
part of the dolphin (the fluke) is formed from the two membrane
spanning domains as they run through the cell membrane. The
body region, with its attached fins and flippers, rises and curves
over so that the rostral region corresponding to the head and
beak run almost parallel to the membrane surface. The three
subunits curl around each other on an axis of symmetry projec-
ting as a perpendicular from the cell membrane, enclosing
a central space or cavity.
The tip of the P2X receptor stands some 70 A˚ proud of the cell
membrane, its turret formed by loops from each subunit
surrounding a central aperture that is too narrow for hydrated
ions to pass (Figure 3). This turret is formed by the upper hairpin
of a two-stranded b sheet, the three copies of which form thewall
of a slightly widened central cavity as they pass down toward the
cell membrane (the upper vestibule).
Extending laterally from the upper body is the head region,
a relatively poorly conserved tangle of loops and short b strands
that is stabilized by three disulfide bonds in mammalian recep-
tors. Three prolines cluster at the central axis, corresponding
to P89 of the rat P2X2 receptor, which is highly conserved (all
numbering refers to rat P2X2). The surrounding region appears52 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.to stabilize the upper body as a ‘‘brace’’ with respect to the
movements of the lower body that occur during channel
opening. Below P89, the central vestibule widens again, its
wall formed by three-stranded b sheets (Figure 3B). This forms
the lower body region, and amino acid side chains projecting
into the central vestibule give it a strongly acidic surface. The
b sheets extend down to join directly to the outer ends of the
transmembrane domains and, as they do, lateral portals open
between them just above the level of the outer membrane
surface (Figure 3A).
Where ATP Binds
Facing outward from the b sheets that form the wall of the lower
body, some 45 A˚ from the cell surface, one finds the key residues
involved in ATP binding. The triphosphate chain of the ATP
bends in a U shape around the ammonium nitrogen atom of
K69, and oxygen atoms of the a, b, and g phosphates make
several interactions with K69, K70, N288, R290, and K308
(Hattori and Gouaux, 2012; Figure 3D). At least one oxygen
atom of the g phosphate is exposed to surrounding solution.
The ribose ring of ATP likely makes hydrophobic contact with
L211 and I226 (Figure 3D), leaving its 20 and 30 oxygen atoms
exposed to the extracellular solution. The adenine moiety lies
deeper in the binding cavity, its side-chain nitrogen hydrogen
bonding to backbone carbonyl oxygens of K70 and T184 and
itsmain ring nitrogen atom hydrogen bondingwith the side-chain
oxygen of T184. These interactions account for the observed
selectivity of P2X receptors for ATP, rather than CTP, UTP, or
GTP (Hattori and Gouaux, 2012).
How Ions Permeate
The lateral portals between the b strands of the lower body
provide the access route for ions into the central vestibule of
the protein (Hattori and Gouaux, 2012; Kawate et al., 2011;
Samways et al., 2011). These portals are situated just above
the outer membrane surface, ringed by polar side-chains of
Q52 and Q321 (A chain), and I328, D57, E59, and K195 (B chain)
(Figure 3E). They are likely partially occluded by lipid at their
lower edge. They are sufficiently wide in the closed channel to
Table 1. Key Facts and Useful Pharmacopeia for Exploring P2X Receptors
P2X1 P2X2 P2X3 P2X4 P2X5 P2X6 P2X7
Gene name P2RX1 P2RX2 P2RX3 P2RX4 P2RX5 P2RX6 P2RX7
Desensitization (Complete in) Fast (<1 s) Slow (>20 s) Fast (<1 s) Slow (>20 s) Slow (>20 s) — Slow (>20 s)
Pore ‘‘dilation’’ No Yes No Yes — — Yes
PCa/PNa 4.8 2.8 1.2 4.2 1.5 — —
Fractional Ca2+ current (%) 12.4 5.7 2.7 11 4.5 — 4.6
KO made Yes Yes Yes Yes — — Yes
Agonist EC50 Values (mM)
ATP 0.07 1.2 0.5 10 10 12 100
2MeSATP 0.07 1.2 0.3 10 10 9 100
abmeATP 0.3 >300 0.8 >300 >300 >100 >300
BzATP 0.003 0.75 0.08 7 >500 — 20
Antagonist IC50 Values (mM)
Suramin 1 10 3 >500 4 >100 500
PPADS 1 1 1 >500 3 >100 50
TNP-ATP 0.006 1 0.001 15 — — >30
IP5I 0.003 >300 2.8 Potentiation — —
A-317491 >10 >100 0.10 >100 — >100 >100
RO-3 >100 >100 0.10 >100 >100 >100
A-740003 >100 >100 >100 >100 — >100 0.05
AF-353 >10 >10 0.01 >10 >10 >10
A-438079 >100 >100 >100 >100 — >100 0.06
A-804598 >100 >100 >100 >100 — >100 0.01
MRS2179 80 >100 >100 — — >100
NF279 9 30 50 >100 — — 20
NF449 0.7 >100 >100 >100 — — >100
Modulator EC50 Values (mM)
Ivermectin — >30 >30 0.25 — — >30
Zn2+ — Increase
EC50 = 7 mM
— Increase
2 mM
— — Decrease
IC50 = 10 mM
H+ Decrease
pKa 6.3
Increase
pKa 7.3
Decrease
pKa 6.0
Decrease
pKa 6.8
— — Decrease
pKa 6.1
Notes: — Indicates that this information is not yet available. The Pf(%) values are for the rat subunits, but the pCa2+/pNa+ values are also shown for
human and rat isoforms as appropriate for the available data. In the case of suramin and PPADS IC50 values the data for P2X4 are highly species-
dependent. For further details, see Jarvis and Khakh (2009) and Coddou et al. (2011).
Abbreviations used in the table: ATP, adenosine 50-triphosphate; 2MeSATP, 2-methythioadenosine 50-triphosphate; abmeATP, alpha beta methylene
adenosine 50-triphosphate,; BzATP, 20,30-O-(4-benzoylbenzoyl)-ATP; PPADS, pyridoxal-50-phosphate-6-azophenyl-200,400-disulphonic acid; TNP-ATP,
20,30-O-(2,4,6-trinitrophenyl) adenosine 50-triphosphate; IP5I, diinosine pentaphosphate; A-317491, 5-({(3-phenoxybenzyl)[(1S)-1,2,3,4-tetrahydro-
1-naphthalenyl]amino}carbonyl)-1,2,4-benzenetricarboxylic acid; RO-3, 5-(2-isopropyl-4,5-dimethoxybenzyl)pyrimidine-2,4-diamine; A-740003,
N-[1-(N00-cyano-N0-quinolin-5-ylcarbamimidamido)-2,2-dimethylpropyl]-2-(3,4-dimethoxyphenyl)acetamide; AF-353, 5-(5-iodo-2-isopropyl-4-
methoxy-phenoxy)-pyrimidine-2,4-diamine; A-438079, 3-(5-(2,3-dichlorophenyl)-1H-tetrazol-1-yl)methyl pyridine; A-804598, 2-cyano-1-[(1S)-1-
phenylethyl]-3-quinolin-5-ylguanidine, MRS2179: 20’-deoxy-N6-methyl adenosine 300,500diphosphate; NF279, 8,80-(carbonylbis(imino-4-1-phenylene-
carbonylimino-4,1-phenylenecarbonylimino))bis(naphthalene)-1,3,5-trisulfonic acid; NF449, 4-[({3-[({3,5-bis[(2,4-disulfophenyl)carbamoyl]phenyl}
carbamoyl)amino]-5-[(2,4-disulfophenyl)carbamoyl]phenyl}carbonyl)amino]benzene-1,3-disulfonic acid.
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channel opening (Figure 3E). Ions passing through these portals
enter the central vestibule, where the excess of negative charges
on its inner wall probably serves to concentrate cations. A role in
ion selectivity for the portals themselves is indicated by the
observation that mutation of some of their negatively charged
side-chains changes the relative permeability of calcium (Sam-
ways et al., 2012; Samways and Egan, 2007).The permeation pathway through the cell membrane forms
down the central axis of the three tilted TM2 domains. They
are widely separated at the outer membrane surface (Figure 3B),
but the extracellular vestibule formed within them narrows as the
TM2s approach and cross each other. In the closed structure,
the first narrowing occurs at the level of T336, but the narrowest
part of the transmembrane pore is formed one helical turn further
along TM2 at T339 (Figures 3A and 3B). At this point, side chainsNeuron 76, October 4, 2012 ª2012 Elsevier Inc. 53
Figure 2. P2X Receptors Define a Unique Family of Ligand-Gated Ion Channels
Trimeric, tetrameric, and pentameric ligand-gated ion channels, viewed from the outer surface. (Left) P2X receptor family. ATP-gated P2X4 cation channel from
zebrafish (Danio rerio) in an open state. Modified from 4DW1. (Middle) AMPA receptor family. Glutamate-gated GluA2 cation channel from rat, in closed state
(Rattus norvegicus). Modified from 3KG2. (Right) Nicotinic acetylcholine receptor family. Glutamate-gated chloride channel from the nematode worm
(Caenorrhabditis elegans) in open state. Modified from 3RHW.
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Reviewocclude the channel when closed, and project into it when open.
When T339 is replaced by lysine in one, two or three of the
subunits, the unitary conductance is reduced stepwise, and
the relative chloride permeability is similarly increased, suggest-
ing a critical interaction with permeating ions (Browne et al.,
2011). Thus, the side chains of T339 which occlude the
permeation pathway in the closed channel (Figure 3B) also
form the narrowest part of the constriction of the open channel
(Hattori and Gouaux, 2012). In the P2X2 receptor, the side chain
of the next residue along the helix (S340) also becomes acces-
sible to the permeating ions as the helices separate during
channel opening: positively charged substitutions here markedly
increase outward currents (Cao et al., 2009), probably as a
result of increasing permeability to chloride ions (Browne et al.,
2010).
Passing further into the cell, the splaying TM2 domains
enclose a widening intracellular vestibule. A conserved glycine
residue situated one helical turn interior to T339 (G342) allows
TM2 to kink during channel opening (Fujiwara et al., 2009; Hattori
and Gouaux, 2012). The importance of this helix bend is unclear,
but it is known that addition of a side chain at this position by
mutagenesis does not prevent the response to ATP (Cao et al.,
2009; North, 2002). Indeed, in the P2X4 receptor, the identity
of such a side chain profoundly alters kinetic behavior (Khakh
et al., 1999a). The side chain at this position would not protrude
toward the permeation pathway of the closed channel, and these
effects likely result from stabilization of an open dilated confor-
mation (see below).
The side chain of the V343 is orientated toward the center of
the permeation pathway, and this is consistent with the observa-
tion that a high affinity metal binding site may be formed here by
cysteine substitution (Li et al., 2010), although the cadmiumblock
reversed with washout. Cadmium also has some blocking effect
at S345 and D349, but the further splaying of the helices as one
passes into the cell makes it unlikely that this results from stable
coordination within the central axis of the pore (Kracun et al.,
2010). At S345 Cb radii are 12 A˚ and 11 A˚ for open and closed
channels and at D349 the radii are 10 A˚ (open) and 16 A˚ (closed)
(Figure 3B). The electronegativity at D349 may serve a ‘‘cation
concentrating’’ role in the inner vestibule (Cao et al., 2009).54 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.From Closed to Open
ATP binding initiates several substantial rearrangements (Jiang
et al., 2012; Lo¨rinczi et al., 2012; Roberts et al., 2012). The first
step may be the disruption of the strong repulsion between the
quaternary nitrogen atoms of K308 (on b14 of chain A) and K69
(on b1 of chain B) as the highly negative phosphate tail of ATP
is drawn into the binding cleft. These nitrogen atoms are 8 A˚
apart in the closed structure, and approach to 4 A˚ in the open
structure when they interact with negative oxygen atoms on
the phosphate chain. R290 (on b13 of chain A) forms a salt bridge
with E167 (projecting down from the head domain of the same
subunit) in the closed channel: this is exchanged for a salt bridge
with the g phosphate of ATP (R. Hausmann and G. Schmalzing,
personal communication; Figure 3C). The lateral movement of
Q138 allows the head domain to drop down. At the same time,
S284 on the left flipper retracts clear of the binding cleft. On
the B chain an upward movement of the dorsal fin allows it to
make hydrophobic interactions with the ribose moiety and
adenine base, principally through L211 and I226 (Figure 3E). Of
interest, the dorsal fin of the P2X7 receptor lacks one helical
turn, which includes the first of these two hydrophobic residues:
this might contribute to the relative insensitivity to ATP shown by
this subtype.
The downwardmovement of the head domain can be followed
by the approach of H120 to H213. Nagaya et al. (2005) showed
that these residues contributed to an intersubunit zinc binding
site and that, when H120 and H213 are both replaced by
cysteine, a new intersubunit disulfide can form which inhibits
channel opening. The intimate approximation of the head
domain (chain A) with the dorsal fin (chain B) appears to be in
itself sufficient to lead to channel opening in a suitably mutated
‘‘reporter’’ receptor (Jiang et al., 2012).
The movements of the left flipper (chain A) and dorsal fin
(chain B) exert tension on the b sheeted wall of the lower body
of the same subunit, causing it to flex outward by a slight sepa-
ration of its constituent b sheets and increasing its circumference
by a progressively greater amount as it passes down toward
the outer surface of the membrane (Roberts et al., 2012). Here,
at the outer end of TM2 the ‘‘diameter’’ increases from 18 to
32 A˚ (Figure 3C). This widening of the lower body causes the
Figure 3. P2X Receptor Structure, the ATP Binding Site, and the Permeation Pathway
(A) Assembly of P2X2 receptors from three subunits, depicted in closed (left) and open (right) states. Upper, middle, and lower panels show one, two, and three
subunits.
(B) Cross-sections of open and closed rat P2X2 receptors, at the level of the residues indicated, the Cb atoms of which are shown as spheres. Number in lower
right of each panel is the diameter of the circle (in A˚), passing through the three Cb atoms. D349 viewed from below, others viewed from above.
(C) Key residues in the ATP binding pocket, in open and closed configurations. Two subunits depicted.
(D) ATP molecule positioned in binding pocket. The U-shape of the triphosphate chain curls around the nitrogen atom of K69. Further explanation in text.
(E) The lateral portal between two subunits (blue and yellow; pink subunit visible through the portal). Key residues on the edge of the portal are indicated.
(F) Schematic to illustrate iris-like movement of TM2 domains. Molecular models created in Modeler 9v7 (Sali and Blundell, 1993) using 4DW0 (closed) and 4DW1
(open) as templates, energy minimized using MolProbity (Davis et al., 2007) and displayed in Chimera 1.6 (Pettersen et al., 2004).
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Reviewtransmembrane helices to separate at their outer ends, and
expands the pore like a three-leafed iris (Figure 3F).
Caveats and Limitations
The foregoing interpretation and description gives a compelling
account of how a P2X receptor can bind ATP and transform
from a closed to an open state. Yet there are caveats and limita-
tions. The first is that the determination of a single open structure
does not preclude the existence of other stable forms, and obvi-
ously it does not address the movements that occur in the most
flexible parts of the protein. Studies using normal mode analysis
and molecular dynamic simulations (Du et al., 2012; Jiang et al.,
2012) are likely to be most informative in providing insight into
conformational dynamics. Additionally, the zebrafish P2X4
receptor used for crystallography lacked intracellular N and C
termini, which will likely have an effect on channel properties.
Likewise, the membrane proximal regions of these N- and
C-terminal domains contain conserved motifs in which minor
substitutions can impair receptor function (North, 2002). There
is also evidence that these membrane proximal intracellular
regions are involved in desensitization (Werner et al., 1996),
and the molecular rearrangements underlying desensitization
remain unclear. Further, P2X receptors have three ATP binding
sites (Bean et al., 1990), and the present structures provide little
insight into the molecular basis of the observed cooperativity
(Ding and Sachs, 1999; North, 2002). Finally, the stationary snap-
shots and nanosecond simulations leave us with much to learn
about the kinetics of receptor activation and how these proteins
may be better suited to respond to longer-lasting diffusing
signals than to the short, sharp pulses of a fast transmitter.
Drugs and Allosteric Modulators
There has been considerable activity in the drug development
world focused on P2X receptors, and this has beenwell reviewed
(Coddou et al., 2011; Ford, 2012). The ATP-bound structure of
Hattori and Gouaux (2012) shows clearly how molecules such
as TNP-ATP could be accommodated in the ATP binding pocket
of the receptor. Wolf and colleagues (2011) have studied NF770,
a derivative of suramin, which blocks P2X2 receptors at about
20 nM (Wolf et al., 2011). By homology modeling and docking,
they demonstrated a direct hydrogen bond between R290
(critical for ATP binding, see Figures 3D–3F) and the methoxy
oxygen atom of NF770, thus accounting for its high affinity as
a competitive antagonist.
Ivermectin strongly potentiates ATP-induced currents at P2X
receptors, and this effect is largest for P2X4 receptors (Khakh
et al., 1999b). Residues involved in ivermectin binding have
been identified on both TMs as lipid-facing (Jelı´nkova et al.,
2008; Silberberg et al., 2007). The ATP-bound structure confirms
the outward facing orientation of these residues around the helix
crossing point and substantiates the suggestion by Silberberg
et al. (2007) that ivermectin interacts at the protein-lipid interface
so as to stabilize an open state.
Divalent and trivalent cations have been used extensively to
probe the ectodomain function of P2X receptors (Coddou
et al., 2011). There are two salient areas. The first is that all
P2X receptors are exquisitely sensitive to the concentrations of
normal extracellular ions: all the receptors respond to lower
ATP concentrations when the concentrations of extracellular
calcium and magnesium are reduced, effects generally more56 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.marked for P2X7 receptors (Surprenant et al., 1996). Reduction
of extracellular magnesium will increase the fraction of ATP
that is in the uncoordinated (ATP4-) state, which is now known
to be the active binding form, but this effect should be equal
for all receptors. The importance of the divalent ions is particu-
larly seen with P2X7 receptors, where the reduction in calcium
and magnesium concentrations strongly promotes ‘‘dilatation’’
and divalent ions appear to serve as ‘‘coagonists’’ (Jiang et al.,
2005; Shinozaki et al., 2009; Surprenant et al., 1996). A similar
behavior underlies the astonishing property of P2X3 receptors
to ‘‘remember’’ for many minutes a brief exposure to a higher
than normal concentration of calcium ions (Cook et al., 1998).
This action was ascribed to an acceleration of recovery from
a very long-lived desensitized state.
Gadolinium was present in the solution used to grow the first
crystals of the zebrafish P2X4 receptor, and gadolinium
(100 mM) completely inhibits ATP currents at those receptors
(Kawate et al., 2009). X-rays showed it unequivocally to be
present in the upper part of the central vestibule, coordinated
by E98 from each of the three subunits, but also on the external
surface of the body domain, one ion per subunit. In this latter
position, the gadolinium is coordinated by carboxylates from
D184 and N187. Any general significance of this finding seems
unlikely: zfP2X4 D184 is not well conserved among P2X recep-
tors, whereas the Asp at position 187 is conserved but glycosy-
lated (Lenertz et al., 2010; Newbolt et al., 1998; Roberts and
Evans, 2006).
Pore Dilation
Although all functional P2X receptors undergo conformational
changes that result in the opening of a cationic pore within
milliseconds of ATP binding, some P2X receptors (notably
P2X2, P2X4, and P2X7) also undergo additional slower con-
formational changes (Figure 4). Pore dilation follows several
seconds of ATP activation and is characterized by increases in
permeability to organic cations and several dyes (Khakh et al.,
1999a; Khakh and Lester, 1999; North, 2002; Virginio et al.,
1999). In other P2X receptors, notably P2X1 and P2X3, extended
activation by ATP results in channel closure through desensitiza-
tion. Pore dilation is of interest because it occurs over seconds,
endowing P2X receptors with slow signaling capabilities and
potentially providing the ability to release intracellular constitu-
ents such as ATP itself.
Two mechanisms have been proposed for pore dilation
(Figure 4). For P2X2, P2X4, and P2X7 receptors, pore dilation
appears to involve an intrinsic conformational change in the
protein itself (Chaumont and Khakh, 2008; Khadra et al., 2012;
Yan et al., 2008, 2010, 2011). However, for natively expressed
P2X7 channels, an accessory protein may also be required,
and pannexin-1 channels may be involved in receptor pore dila-
tion (Jiang et al., 2005; Pelegrin and Surprenant, 2006; Pelegrin
and Surprenant, 2007; Surprenant et al., 1996) in a manner that
varies with the particular splice variant being studied (Xu et al.,
2012). In all cases, the dilated pore state is regulated by cellular
processes and mechanisms that involve the C-terminal tail. In
the case of P2X4 receptors, fast-scanning atomic force micros-
copy has been used to image a slow conformational change that
may underlie the phenomenon within single protein molecules
(Shinozaki et al., 2009).
Figure 4. Examples and Models of Slow
Conformational Changes in P2X Receptors
Displaying Pore Dilation
(A) Current-voltage plots for example recordings
of the I1 and I2 states for P2X2 receptors ex-
pressed in Xenopus oocytes are shown. The I1
state has low permeability to the organic cation
NMDG+ (hence a negative reversal potential). With
time the permeability to NMDG+ increases, indi-
cated as a shift in reversal potential by +16 mV.
(B) Representative images of a Xenopus oocyte
bathed in YOPRO-1 before and during 100 mM
ATP (for 30 s). The oocyte becomes fluorescent as
YOPRO-1 enters the cell, presumably via the I2
state. The data shown in (A) and (B) are from
supplementary information accompanying Chau-
mont and Khakh (2008) (copyright 2008, National
Academy of Sciences, USA).
(C) Diagrams illustrating the differences between
the Pannexin-1 and gating models for the I2 state.
In the gatingmodel, small cations, organic cations,
and dyes enter due to slow conformational
changes in the P2X pore. In the Pannexin-1model,
organic cations and dyes enter via an accessory
ion channel protein called Pannexin-1. On balance
the field is converging on the gating model, but
there is also evidence for the Pannexin-1 model in
the case of P2X7 receptors that are natively ex-
pressed (as discussed in the main text). In both
models, the cytosolic domains of P2X receptors
are important.
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frequency detectors, by switching to the larger pore state with
altered signaling upon repeated ATP activation (Khakh et al.,
1999a). Recent data suggest that this particular state of P2X7
receptorsmay be involved in susceptibility to chronic pain (Sorge
et al., 2012), raising the possibility that pore dilation of other P2X
receptors in the brain may also mediate important slow
responses. Further structural as well as physiological studies
are needed to evaluate precisely how pore dilation and dynamic
selectivity filters occur and what their functions are in vivo.
Functional Interactions of P2X Receptors with Other Ion
Channels
P2X and nicotinic receptors undergo functional interactions
(Barajas-Lo´pez et al., 1998; Nakazawa, 1994; Nakazawa et al.,
1991; Searl et al., 1998; Searl and Silinsky, 1998; Zhou and
Galligan, 1998). Coexpression of P2X2 and a3b4 nicotinic recep-
tors in Xenopus oocytes provided evidence for functional inter-
actions resulting in cross inhibition: the activation of one channel
type affected distinct kinetic and conductance states of the
other, and coactivation resulted in nonadditive responses
owing to inhibition of both channel types (Khakh et al., 2000).
This study also showed that the functional interactions occurred
in synaptically coupled myenteric neurons where nicotinic fast
excitatory postsynaptic currents were occluded during activa-
tion of endogenously coexpressed P2X channels. Similar exper-
iments have now been repeated with several ion channel combi-
nations showing that cross-inhibition between P2X receptors
and members of the nicotinic receptor-like family are commonNeuron 7(Barajas-Lo´pez et al., 1998, 2002; Boue´-
Grabot et al., 2003, 2004a, 2004b). Most
recently, functional interactions havebeen reported for P2X receptors and acid sensing ion channels
(ASIC) (Birdsong et al., 2010) as well as between P2X3 receptors
and TRPV1 channels (Stanchev et al., 2009). We comment here
on general themes that emerge.
Overall, the data suggest P2X receptors form molecular scale
partnerships with distinct ion channels. Fluorescence resonance
energy transfer (FRET) experiments show close interactions
between P2X2 and a4b2 nicotinic, P2X5 and ASIC, as well as
P2X2 andGABAA receptors,which provides abasis for functional
interactions within the plasma membrane (Birdsong et al., 2010;
Khakh et al., 2005; Shrivastava et al., 2011). Cross-inhibition
between P2X receptors and nicotinic channels can occur in the
absence of ion flow through P2X2 during a closed-desensitized
state and is likely due to conformational coupling (Khakh et al.,
2000). Similarly, the interaction between P2X5 and ASIC
channels is independent of ion flow through P2X5 receptors
(Birdsong et al., 2010). In the case of spinal neurons, activation
of P2X2 receptors increases the lateral mobility of GABAA recep-
tors, adding a previously unknown facet to the interactions
between these receptor types (Shrivastava et al., 2011). An
important question for future exploration is to determine if
cross-inhibition has behavioral consequences, either physiolog-
ically or during disease states, and it will also be important to nail
down the molecular basis for the interactions.
Activation-Dependent Regulation of P2X Receptors
P2X receptors are regulated in a use-dependent manner and
it is likely these mechanisms contribute in important ways to
their neuromodulatory responses in the brain. To date, two6, October 4, 2012 ª2012 Elsevier Inc. 57
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tion by Ca2+ sensors.
P2X4 receptors display several types of dynamic trafficking
including endocytosis, lysosomal secretion and lateral mobility.
A robust observation has been the role of trafficking of P2X4
receptors through dynamin-dependent endocytosis, and P2X4
receptors undergo constitutive and regulated endocytosis medi-
ated by a novel noncanonical endocytic motif (YXXGL) (Boba-
novic et al., 2002; Royle et al., 2002, 2005). Additionally, owing
to the their extensive glycosylation, P2X4 receptors are resistant
to lysosomal degradation and can be secreted from lysosomes
to deliver a pool of functional ion channels to the cell surface
(Qureshi et al., 2007). Most recently, these insights have been
extended to studies of P2X4 receptors within microglia, and it
has been shown that both lysosomal secretion and plasma
membrane lateral mobility of P2X4 receptors are increased by
activation of the microglia (Toulme et al., 2010; Toulme and
Khakh, 2012).
A second form of activity-dependent regulation has been
demonstrated for P2X2 and P2X7 receptors and is mediated
by the Ca2+ sensor proteins VILIP1 and calmodulin, respectively
(Chaumont et al., 2008; Richler et al., 2011; Roger et al., 2008). In
both cases, Ca2+ fluxes mediated by these P2X receptors result
in the recruitment of the cognate Ca2+ sensor to the C-terminal
domain of the channel to regulate functional responses. The
consequences are subtle for P2X2 receptors, but result in
profound facilitation of P2X7 receptor responses (Roger et al.,
2008). The interaction with VILIP1, which occurs during endoge-
nous ATP release, requires slow conformational changes re-
sulting in exposure of a VILIP1 binding site in the cytosolic
C-terminal tail of P2X2 receptors (Chaumont et al., 2008; Chau-
mont and Khakh, 2008). Single-molecule experiments reveal that
the interaction between P2X2 receptors and VILIP1 regulates
plasma membrane lateral mobility of P2X receptors in neuronal
dendrites (Richler et al., 2011), perhaps serving to affect re-
covery from desensitization by controlling the supply of recep-
tors. Determining the full repertoire of proteins that interact
with P2X2, P2X4 and P2X7 will help illuminate how these recep-
tors are tuned to perform their tasks in vivo.
Single-molecule imaging experiments now provide accurate
and consistent values for P2X2, P2X4, and P2X7 receptor diffu-
sion coefficients in the plasma membrane (0.027, 0.023, and
0.021 mm2/s, respectively) (Arizono et al., 2012; Richler et al.,
2011; Toulme and Khakh, 2012). In the case of P2X2 and P2X4
receptors, activation by ATP causes the receptors to diffuse
twice as fast in a cell- and subunit-specific manner (Richler
et al., 2011; Toulme and Khakh, 2012). Accurate P2X receptor
diffusion coefficients will be invaluable in modeling receptor
movement and plausible roles for lateral mobility in recovery
from desensitization during physiological activation such as
would occur during point source-like ATP release in vivo.
Cells and Mechanisms
Some General Points
P2X receptors are often expressed at low levels, generally in
specific compartments such as the edges of spines and within
nerve terminals (Leˆ et al., 1998; Rubio and Soto, 2001; Vulcha-
nova et al., 1996) and are activated by quite high amounts of58 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.ATP. It seems that sufficient ATP to activate extrasynaptic
P2X2 receptors is only released during bursts of action potentials
(Richler et al., 2008), suggesting that P2X receptors underlie
neuromodulatory responses. Also, we are aware of no example
in the brain or spinal cord where endogenous ATP release stim-
ulates postsynaptic P2X receptors to trigger action potential
firing (i.e., is a primary fast synaptic transmitter). In this respect,
ATP shares features in common with other neuromodulators,
such as ACh and serotonin, which also to appear to mediate
fast synaptic transmission only rarely in the central nervous
system. In these settings, P2X receptor responses may require
downstream signaling or protein interactions and not necessarily
depolarization of the membrane. Indeed, P2X receptors carry
significant Ca2+ fluxes at resting membrane potentials (Egan
and Khakh, 2004).
Multiple P2X receptor knockout mice have been generated, all
of which survive to adulthood (Chessell et al., 2005; Cockayne
et al., 2000, 2005; Mulryan et al., 2000; Souslova et al., 2000;
Ulmann et al., 2008). Few immediately obvious CNS phenotypes
have been reported, yet these same mouse models show that
P2X channels are strongly involved in a whole host of patholo-
gies. Thus, it appears that endogenously released ATP does
not generally affect the immediate integrative properties of
neuronal circuits, but pathological alterations in signaling can
have profound effects.
Fast ATP P2X Receptor-Mediated Synaptic
Transmission in the CNS: Small and Underwhelming
The first evidence for fast ATP synaptic responses in the brain
was provided in the medial habenula (Edwards et al., 1992,
1997). Since then evidence for ATP as a synaptic transmitter
has been provided in the locus coeruleus (Nieber et al., 1997;
Silinsky et al., 1992), the hippocampus (Mori et al., 2001; Pankra-
tov et al., 1998, 2002), in spinal neurons (Bardoni et al., 1997; Jo
and Schlichter, 1999), hypothalamic neurons (Jo et al., 2011; Jo
and Role, 2002) and cortex (Lalo et al., 2007; Pankratov et al.,
2003, 2007). While these studies found evidence for ATP
synaptic transmission, in all cases the interpretation that P2X
receptors are involved is based on the use of P2X antagonists
and agonists that are known to be imperfect in their selectivity
(Khakh et al., 2001; North, 2002). Also, none of these studies
employed P2X receptor subunit knockout mice or provided
a detailed pharmacological/biophysical characterization of the
underlying P2X receptors (Table 1 shows the emerging useful
pharmacopeia of P2X receptors). Additionally, ATP-mediated
EPSCs detected in this manner tend to be small (about 10% of
the size of EPSCs mediated by glutamate), infrequent, only
observed in subpopulations of neurons within a given brain
nucleus, and they generally require strong electrical stimulation
to evoke. There is little evidence that the small EPSCs are phys-
iologically effective in the neurons from which they were
detected. Thus, the evidence in favor of ATP as an important
synaptic neurotransmitter mediating fast synaptic potentials in
the brain remains weak.
The evidence for ATP as a fast synaptic neurotransmitter with
important functional roles is much stronger in the periphery, for
example at neuroeffector junctions (Mulryan et al., 2000; Sned-
don and Burnstock, 1984; Sneddon et al., 1982), neuroneuronal
synapses (Evans et al., 1992) and in the gastrointestinal system
Figure 5. Summary Showing Locations of P2X
Receptors in Synapses
Note: this is a cartoon summarizing twenty years of work
on various synapses. As such we are not aware of any
synapse that expresses P2X receptors in all the locations
shown in this cartoon. ATP is released from astrocytes
from lysosomes, vesicles, and through hemichannels. All
three of these release mechanisms need to be considered
on a case-by-case basis, because it is likely that they
operate in different settings and in different brain nuclei.
Electron microscopy and single molecule imaging shows
that P2X2 and P2X4 receptors do not enter synapses
(Masin et al., 2006; Richler et al., 2011; Rubio and Soto,
2001), implying the existence of a restrictive barrier which
is shown here as a gray bar at the edge of the postsynaptic
density.
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feature of these papers is that key experiments have been
repeated in P2X1 and P2X2 subunit knockout mice, and the
underlying receptors have been characterized in detail.
Neuromodulatory Influences of Postsynaptic P2X
Receptors: A Diversity of Mechanisms
Three noteworthy studies suggest that ATP signaling via post-
synaptic P2X receptors plays a neuromodulatory role at brain
synapses. The first concerns the role of P2X receptors in long-
term synaptic potentiation (LTP) of glutamate synapses onto
CA1 pyramidal neurons (Pankratov et al., 2002). In this case,
Ca2+ flux through P2X receptors dampens NMDA receptor-
dependent LTP at low frequencies of action potential firing in
Schaffer collateral axons (Pankratov et al., 2002). Consequently,
when P2X receptors are blocked, NMDA receptor-dependent
LTP occurs at lower action potential frequencies. Second, recent
studies have utilized P2X4 receptor knockout mice to analyze
synaptic transmission and plasticity in CA1 pyramidal neurons,
and no evidence for a role of P2X4 receptors in excitatory
synaptic transmission was found (Baxter et al., 2011). Moreover,
although the P2X4 deletion mice display subtly reduced LTP
(Sim et al., 2006), ATP fast synaptic transmission does not
seem to be the cause, and the data suggest that Ca2+ entry
through P2X4 receptorsmay regulate NMDA receptor incorpora-
tion into fast synapses (Baxter et al., 2011). A third set of exper-
iments suggest roles for P2X4 receptors in inhibitory synaptic
transmission onto a specific population of steroidogenic factor 1
(SF-1) positive neurons in the ventromedial nucleus of
the hypothalamus (Jo et al., 2011). Blocking P2X4 receptor
endocytosis increases responses evoked by exogenous ATP
in SF-1 neurons, but no evidence was found for fast ATP
synaptic transmission. However, blocking P2X4 endocytosis
reduced inhibitory IPSCs, which appears to be due to increased
cross inhibition between P2X4 receptors and synaptic GABAA
receptors.
Demonstrating synaptic consequences for the interaction
between P2X and other receptor classes is relevant to future
efforts to explore the physiological roles of P2X receptors inNethe brain. From this perspective, the interac-
tions between P2X5 and ASIC channels are
particularly noteworthy (Birdsong et al., 2010),
as they demonstrate strong functional interplaybetween the two ion channels in a manner that utilizes a P2X
receptor subunit that is only weakly functional as a homomer
(Collo et al., 1996). In this case, the interaction is independent
of ion flow through the P2X receptor and dependent on a molec-
ular interaction between the cognate subunits reminiscent of
interactions between P2X and nicotinic receptors (Khakh et al.,
2005). One should consider, therefore, the realistic possibility
that seemingly silent P2X receptors in brain neurons may none-
theless be exerting important modulatory influences on other ion
channels, particularly in cases such as ischemia when ATP is
known to be released in high amounts (Birdsong et al., 2010).
Overall, recent studies that employ knock-out mice or other
more specific molecular interventions suggest that P2X recep-
tors modulate fast synaptic responses mediated by other more
established fast neurotransmitters. Consistent with this sugges-
tion, electron microscopy shows that P2X2 and P2X4 receptors
are generally not located in synapses at sites directly opposite
neurotransmitter release from the presynaptic terminal (Figure 5),
residing instead at the edges of the postsynaptic density (Rubio
and Soto, 2001). Recent single molecule imaging and tracking
experiments in cell culture support these findings and show
that P2X2 receptors do not enter fast glutamatergic synapses
even when heterologously overexpressed and strongly activated
by ATP (Richler et al., 2011). These data offer an explanation for
the rarity of fast ATP neurotransmission in the brain and also
raise important cell biological questions about why P2X recep-
tors are excluded from synapses.
Presynaptic P2X Receptors and the Control of Release
Probability
In general, activation of presynaptic P2X receptors increases
neurotransmitter release probability due to influx of calcium
(Figure 5), although depression of action potential evoked neuro-
transmitter release can also occur as a result of action potential
failure and/or shunting in axons (Engelman and MacDermott,
2004; Khakh and Henderson, 2000). Presynaptic P2X receptors
may be activated by endogenous ATP release in some syn-
apses. Although, presynaptic P2X responses have now been
described in many parts of the brain, we lack a satisfactoryuron 76, October 4, 2012 ª2012 Elsevier Inc. 59
Figure 6. Cartoon summary of Synaptic
Scaling by ATP Acting on P2X Receptors in
Magnocellular Neurons (MCNs) of the
Hypothalamus
The schematic is based on work by the Bains lab
(Gordon et al., 2005, 2009). Glutamate and
noradrenaline cause release of intracellular Ca2+
within astrocyte processes, leading to ATP release
in to the extracellular milieu. This activates extra-
synapticP2X receptors,which through aCa2+- and
PI3K-dependent mechanism, leads to synaptic
scaling by insertion of AMPA receptors into
dendritic spines of MCNs. The astrocyte Ca2+
signals may spread within astrocytes leading to
similar effects at other synapses. The effects of
glutamate and noradrenaline in this context are
both reduced when astrocyte processes withdraw
from MCNs during lactation and dehydration (see
text for details). In this context, the astrocyte
process is not actively contributing to synaptic
transmission, but rather via ATP it is exerting
a strong activation-dependent neuromodulation.
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of presynaptic facilitation.
A presynaptic action of ATP forms one aspect of its overall
effect in the hippocampus, within the feed-forward circuit
formed between CA3 pyramidal neurons, GABAergic interneu-
rons and output CA1 pyramidal neurons. Progress from several
groups is beginning to converge and suggest ways in which
ATP signaling may be involved in the integrative actions of this
circuit. Presynaptic P2X2 receptors increase glutamate release
onto interneurons but not pyramidal neurons (Khakh et al.,
2003), whereas postsynaptic P2Y1 receptors depolarize inter-
neurons (Bowser and Khakh, 2004; Kawamura et al., 2004).
However, most likely because there are few pre- or postsynaptic
ATP receptors that depolarize CA1 pyramidal neurons directly
(Baxter et al., 2011; Khakh et al., 2003), the net effect on output
neurons is dominated by heightened GABAergic synaptic inhibi-
tion. Thus, in the stratum radiatum region of the hippocampus,
the cellular effects of ATP are excitatory, but the overall result
on the network is dominated by increased inhibition, implying
that ATP acts as a ‘‘physiological brake’’ to excitation within
this feed-forward circuit (Bowser and Khakh, 2004). Recent
studies show that this type of inhibition by ATP is indeed
engaged via ATP release from astrocytes through connexin
hemichannels, triggered by activity-dependent decreases in
extracellular Ca2+ levels within the hippocampal circuit and
propagated by slow astrocyte Ca2+ signaling mediated by ATP
(Torres et al., 2012).
Multiplicative Scaling of Synaptic Efficacy by P2X
Receptors in Magnocellular Neurons of the
Hypothalamus
One of the best examples of neuromodulation by ATP acting at
P2X receptors is in magnocellular neurons (MCNs) of the hypo-
thalamus (Figure 6). Endogenous ATP acting at extrasynaptic
P2X receptors plays a crucial role in modulating excitatory
synaptic transmission in MCNs (Gordon et al., 2005, 2009). Early
work suggested that ATP mediates part of the excitatory drive to
MCNs following activation of catecholamine containing cells
(Day et al., 1993), and electrophysiological studies showed
that MCNs expressed functional P2X receptors that mediated60 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.membrane potential depolarization and increases in membrane
conductance (Hiruma and Bourque, 1995). Later studies found
ample evidence for the presence of P2X receptor mRNAs and
proteins that mediated ATP-evoked inward currents and strong
elevations in intracellular Ca2+ levels in MCNs. It seems MCNs
express a mixture of P2X receptors containing P2X2, P2X4,
and possibly P2X7 subunits (Vavra et al., 2011).
It has been shown that P2X receptor signaling mediates
the effect of noradrenaline (NA) on AMPA receptor-mediated
mEPSCs arriving onto MCNs of the rat paraventricular nucleus
(Gordon et al., 2005). Brief applications of NA increased mEPSC
amplitudes for long periods of time, perhaps permanently, by
increasing AMPA receptor insertion into synapses (Figure 6).
NA did not act postsynaptically via adrenoceptors in MCNs;
instead, NA acted on astrocytes to release ATP. This paper
provided strong evidence that ATP acting via P2X receptors
resulted in modulation of glutamatergic synaptic efficacy, and
astrocytes were directly implicated as the source of endogenous
ATP (Gordon et al., 2005). Bains and colleagues have estab-
lished that the ATP signaling mechanism is engaged during
afferent activity, thus demonstrating that the effects of endoge-
nous astrocyte derived ATP are likely to be utilized in vivo during
physiological action potential firing impinging on MCNs (Gordon
et al., 2009).
The work on MCNs also provides several interesting points
that may be relevant more broadly to the study of brain P2X
receptor-mediated signaling. First, the authors failed to find
fast ATP synaptic transmission. Second, they found that
the sources of endogenous ATP were astrocytes rather than
neurons, and that bursts of action potentials were needed to
engage astrocyte signaling. Third, activation of P2X receptors
resulted in multiplicative scaling of all synapses in MCNs. Multi-
plicative scaling is a form of homeostatic plasticity, whose
underpinnings are only beginning to be explored. Perhaps P2X
receptors are also involved in other areas of the brain in this
form of plasticity? Fourth, the effect of P2X receptor activation
on synaptic efficacy in MCNs took many minutes to develop,
even though P2X receptor activation occurs in seconds once
ATP is bound (Vavra et al., 2011). Fifth, recent data suggest
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nucleus, where their activation facilitates glutamate and GABA
release (Vavra et al., 2011). The neurosecretory cells of the hypo-
thalamus thus emerge as the best characterized model system
to explore the dynamic neuromodulatory influences of pre- and
postsynaptic P2X receptors (Figure 6).
Astrocyte P2X Receptors and the Regulation of Cortical
UP States by Astrocytic ATP
Astrocytes are increasingly recognized as important cellular
elementswithin neuronal circuits not only for providingmetabolic
and structural support to neurons, but also for their ability to
regulate neuronal function through a variety of mechanisms
(Attwell et al., 2010; Halassa and Haydon, 2010). Cortical astro-
cytes express functional P2X7 and P2X1/5 receptors (Lalo et al.,
2008; Oliveira et al., 2011) in distinct populations of astrocytes
in the somatosensory and prefrontal cortices, respectively,
although genome-wide analysis of astrocyte mRNA expression
did not reveal any P2X receptor as being particularly enriched
within astrocytes (Cahoy et al., 2008). P2X1/5 receptors on
cortical astrocytesmay be activated by endogenous ATP release
from neurons and mediate Ca2+ fluxes (Palygin et al., 2010).
A recent study demonstrated that astrocytes utilize ATP
signaling to regulate cortical UP states, which are network-
driven membrane depolarizations recorded from cortical
neurons (Poskanzer and Yuste, 2011). During an UP state, the
membrane potential is depolarized for hundreds of milliseconds
and individual neurons fire bursts of action potentials. The avail-
able data do not allow one to conclude whether the key signals/
events are mediated by astrocytic or neuronal P2X receptors;
however, given that cortical astrocytes and neurons both
express P2X receptors, this study provides strong evidence for
how astrocytes function as the source of ATP to regulate
network phenomena that occur on a time scale of hundreds of
milliseconds. In future studies, it will be interesting to explore
the contributions of specific P2X receptors to cortical UP states
using knockout mice and the emerging pharmacology of P2X
receptors and thus attempt to correlate altered UP state
dynamics with possible behavioral deficits. Finally, one wonders
if neuronal P2X receptor signaling scales synaptic efficacy within
principal neurons or interneurons of the cortex and regulates the
output of the cortical neurons, as seen in MCNs in the hypothal-
amus (Gordon et al., 2005, 2009).
Central Chemoreception and the Control of Respiratory
Drive
An important step in peripheral sensation is activation of P2X and
P2Y receptors on primary afferent terminals. Such responses are
fundamental to nociception (North, 2004) and in ventilatory
responses to hypoxia mediated by the carotid body (Rong
et al., 2003). Recent data suggest that ATP serves similar roles
in the CNS and contributes to the regulation of respiratory drive.
Hypercapnia (an increase in blood CO2; pCO2) increases
breathing, and specific areas of the medulla function as central
chemoreceptors (Feldman et al., 2003). Gourine and colleagues
demonstrated ATP release in micromolar amounts from the
ventral surface of the medulla during hypercapnia (Gourine
et al., 2005). Using miniaturized ATP biosensors, these authors
mapped the sites of ATP release to the retrotrapezoid nucleus
(RTN), an area known to contain pH sensitive neurons (Mulkeyet al., 2004). To explore roles for endogenous ATP in contributing
to respiratory drive during hypercapnia, the authors blocked P2X
and P2Y receptors and observed reduced sensitivity and gain of
the respiratory response to increasing CO2 levels (Gourine et al.,
2005). Exogenous applications of ATP to chemosensitive areas
of the medulla mimicked the effects of CO2 on breathing, and
a P2Y-preferring agonist produced qualitatively different effects,
implying important roles for P2X receptors. Furthermore, studies
in brain slices show that ATP-mediated signaling can affect the
firing properties of RTN neurons, but that chemosensitivity of
these neurons does not derive from ATP (the neurons responded
to changes in pH even when P2X and P2Y receptors were
blocked [Mulkey et al., 2006]). Taken together, these data
suggest that RTN neurons respond directly to pH changes
(Mulkey et al., 2004, 2006) and that another process releases
ATP in response to pH changes to influence the firing properties
of RTN neurons (Gourine et al., 2005).
Recent data suggest that the cellular sources of ATP medi-
ating the purinergic component of the central chemosensory
response to hypercapnia are astrocytes located within the
ventral surface of the medulla (i.e., near the RTN) and that the
astrocytes within this area are particularly pH sensitive (Gourine
et al., 2010). Hence, ‘‘excited’’ astrocytes propagate a Ca2+
signal among them due to intercellular ATP release acting on
P2X and P2Y receptors. Additionally, the authors found that
the acid pH-evoked depolarization of RTN neurons was abol-
ished when ATP signaling was blocked, implying that the
neuronal response was secondary to ATP release rather than
due to intrinsic chemosensitivity of the RTN neurons themselves.
Moreover, the authors found that expression and illumination of
channelrhodopsin within astrocytes led to light-evoked ATP
release and depolarization of RTN neurons via ATP. The use of
channelrhodopsin within an in vivo preparation showed that
light-evoked astrocyte Ca2+ elevations lead to respiratory
activity that was blocked by a mixed P2X1 and P2Y1 receptor
antagonist. Taken together, this study suggests that a key step
in central chemoreception involves ATP release from astrocytes
located on the ventral surface of the medulla, that this signal is
further propagated by ATP release acting on P2X and P2Y
receptors, ultimately arriving at RTN neurons to depolarize
them via ATP receptors that are likely of the P2X1 or P2Y1 class
(Gourine et al., 2010).
Subsequent studies have confirmed that astrocytes release
ATP in response to elevations in pCO2, but in a manner that is
independent of pH changes and by a mechanism involving con-
nexin 26 hemichannels (Huckstepp et al., 2010). Astrocytes in
other parts of the brain may also release ATP in response to
hypercapnia and so the mechanism may not be specific for the
respiratory centers (Dulla et al., 2005). Moreover, recent work
has shown that the purinergic component of the respiratory drive
is at most 30%, a fraction that relies on hemichannel-mediated
ATP release and that the actions of endogenous ATP on
RTN neurons were not mediated by P2Y1 receptors, leaving
open the intriguing possibility P2X receptors play a critical role
(Wenker et al., 2012). Furthermore, in newborn rats, RTN chemo-
reception depends only on the intrinsic chemosensitivity of
neurons (Onimaru et al., 2012). In summary, the available data
indicate that a component of central chemoreception isNeuron 76, October 4, 2012 ª2012 Elsevier Inc. 61
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the RTN, demonstrating how ATP neuromodulation has
profound effects on RTN neuron function with clear behavioral
outcomes in the form of respiratory responses to hypercapnia.
Systems and Mechanisms
Afferent Sensations and Signaling in the Peripheral
Nervous System
Afferent nerves that carry information into the central nervous
system can be excited at their peripheral ends either by direct
mechanical distortion or by transmitters released from special-
ized sensory cells. Considerable evidence now supports the
view that the transmitter released at some such sensory ‘‘first
synapses’’ is ATP, and that it activates P2X receptors on the
primary afferent nerve endings.
Taste and Chemosensation. In response to gustatory stimula-
tion, Type II taste buds release ATP that acts on P2X2/3 hetero-
meric receptors to excite primary afferent nerves that run to
the CNS in the facial or glossopharyngeal nerves (Finger et al.,
2005). Indeed, the release of ATP is itself driven in part by
positive feedback through P2X2 receptors on the taste buds
themselves (Huang et al., 2011). A similar situation pertains
with respect to sensory cells of the carotid body. In this case
the glomus cells sense arterial oxygen levels. In response to
hypoxia they release ATP, and this acts on P2X receptors to
initiate impulses in the carotid sinus nerve (Rong et al., 2003).
Cough. Pulmonary vagal afferents can be directly excited by
activation of P2X2/3 receptors (Kwong et al., 2008), and P2X3
receptor antagonists reduce cough in a commonly used guinea
pig model (Kamei et al., 2005). ATP inhalation in humans induces
cough and dyspnea, likely by direct activation of P2X receptors
(Basoglu et al., 2005). There are now available highly selective
antagonists for receptors containing P2X3 subunits (Gever
et al., 2010) that may prove to have clinical utility.
Urinary Bladder and Intestine. As the bladder becomes
distended, the stretch in its wall can lead to ATP release from
urothelial cells (Ferguson et al., 1997). This excites the terminals
of afferent fibers expressing heteromeric P2X2/3 receptors
(Zhong et al., 2003), and mice with a disrupted P2X3 receptor
gene exhibit bladder hyporeflexia (Cockayne et al., 2000). The
central ends of these primary afferent fibers in the dorsal horn
of the spinal cord also express P2X2/3 receptors, evidenced
by the observation that intrathecal administration of a selective
P2X2/3 receptor antagonist also strongly inhibits the micturition
reflex (Kaan et al., 2010). A similar situation pertains in the intes-
tine, where ATP and abmeATP directly excite mesenteric affer-
ents running from the wall of the small intestine in the rat (Kirkup
et al., 1999). Action potential discharge in pelvic nerve afferent
fibers elicited by colon distension are much attenuated in P2X3
knockout mice (Shinoda et al., 2009; Wynn et al., 2003). These
observations all point to a role for ATP acting directly to excite
primary afferent nerves in physiological and probably patholog-
ical circumstances.
Pain. Interest in P2X receptors and pain dates from early
observations that ATP itself evokes pain when applied to blisters
(Bleehen et al., 1976). This is likely mediated by activation of
P2X3 subunits, which are restricted in their distribution to
a subset of primary afferent neurons (Chen et al., 1995; Lewis62 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.et al., 1995) that also express receptors for capsaicin (TRPV1)
and isolectin B4 (Guo et al., 1999; Vulchanova et al., 1998).
The relevance of this observation to any role in chronic inflamma-
tory or neuropathic pain remains less clear, however. P2X3
knockout mice do have an afferent phenotype, most notably
reduced mechanical allodynia (Cockayne et al., 2000), and
antagonists selective for receptors containing P2X3 subunits
(Jarvis et al., 2002) reduce chronic neuropathic and inflammatory
pain in the rat. Local administration of the P2X2/3 antagonist
A-317491, or prior depletion of P2X3 receptor expression by
intrathecal antisense oligonucleotides, also reduce the mechan-
ical hyperalgesia evoked by carageenan (Oliveira et al., 2009) or
complete Freund’s adjuvant (Ballini et al., 2011). This is consis-
tent with a role for ATP acting on peripherally situated P2X2/3
receptors, as a component of a local ‘‘inflammatory soup.’’
Selective P2X3 receptor antagonists can prevent the mechan-
ical allodynia seen in neuropathic pain models, whether applied
locally or intrathecally (Gum et al., 2012; McGaraughty et al.,
2003). Locally, this is associated with sensitization (an increased
in expression of membrane P2X3 receptors) rather than
increased ATP release (Chen et al., 2005).
Cochlea. Several cells types in the cochlea express P2X
receptors, and their functional roles have been comprehensively
reviewed (Housley et al., 2009). The most compelling is that part
played by ATP released from Ko¨llicker’s organ. This organ
(also known as the greater epithelial ridge) consists of columnar
supporting cells, and it is prominent in the neonatal cochlea
before the onset of hearing. At this developmental stage, ATP
is released from the supporting cells in bursts and depolarizes
the adjacent inner hair cells, causing them to fire bursts of action
potentials which, in turn, excites auditory nerves through release
of glutamate (Tritsch and Bergles, 2010; Tritsch et al., 2007). The
sporadic, spontaneous ATP release begins a few days after
birth and ceases with the onset of hearing. It provides the
primary excitatory stimulus to the auditory nerve during this
period, and this is responsible for the downstream survival and
maturation of auditory neurons.
Retina. An extensive literature pertains to P2X receptor
expression in the retina, both in neurons and in supporting cells
(Housley et al., 2009). The speculation around their roles in
normal function or disease currently lacks insight at the cellular
level, but this is clearly an area worth exploring.
Disease and Mechanisms in the CNS
Pain
Recently, it has been proposed that central P2X4 receptors are
involved in neuropathic pain (Trang and Salter, 2012). The key
evidence here is that removal of P2X4 receptors strikingly
prevents the development of mechanical allodynia following
peripheral nerve injury (Tsuda et al., 2003, 2009; Ulmann et al.,
2008). Peripheral nerve injury is followed by activation of spinal
microglia. It is suggested that ATP acting on P2X4 receptors
drives the release of BDNF from spinal microglia, and that this
in turn is critical for the rewiring that underlies the perception of
mild tactile stimuli as noxious. The neuronal subtypes and
specific microcircuitry involved remain to be elucidated.
P2X7 receptors can also fashion the behavioral responses to
painful stimuli and, in sharp contrast to the situation with P2X4
Neuron
Reviewreceptors, there is now a wealth of pharmacological antagonists
to be used as experimental tools, some of which are in clinical
trials (Gum et al., 2012; Jarvis, 2010). The predominant expres-
sion of P2X7 receptors in the nervous system is on microglia,
astrocytes, and oligodendrocytes. However, some re-interpreta-
tion of experiments which used knock-out micemay be required.
The mice produced by Pfizer (Masin et al., 2012) continue to
express two shortened, alternatively spliced, forms of the P2X7
receptor (P2X7 13B and P2X7 13C). The mice produced by
Glaxo have a functional P2X7 splice variant (P2X7(k)) that
continues to be expressed in these mice: the corresponding
protein is widely expressed, but it has a different N-terminus
and TM1 (Nicke et al., 2009). It forms receptors which are
more sensitive to ATP and which undergo a more rapid increase
in permeability to organic cations (a measure of pore dilation).
The development of mechanical hypersensitivity in models of
neuropathic pain is absent in the Glaxo P2X7 deletion mouse
(Chessell et al., 2005), and a similar phenotype is observed in
mice lacking both isoforms of IL-1b (Honore et al., 2006b).
Mechanical hypersensitivity is also prevented by intrathecal
P2X7 antagonist A-438079 (Kobayashi et al., 2011) and Brilliant
Blue G (He et al., 2012) or systemic administration of P2X7
receptor antagonists (Honore et al., 2006a). These effects in
pain models appear to require release of IL-1b, given that
A-438079 blocks not only the ATP evoked release of IL-1b but
also the release evoked by LPS (Clark et al., 2010). Indeed,
LPS-induced release of IL-1b is absent in lumbar spinal cord
slices from P2X7 deletion mice. These results imply that the
rewiring of microcircuitry in the spinal cord that occurs during
prolonged inflammation or nerve injury involves ATP release,
the activation of P2X7 receptors on spinal microglia, and the
release of IL-1b. Our understanding of the source of ATP has
advanced little since Pamela Holton showed that sensory nerves
release ATP when stimulated electrically (Holton, 1959). As for
the target action of the released IL-1b, one suggestion is that
it leads to increased phosphorylation of the NR1 and NR2B
subunits of the NMDA receptor and perhaps an LTP-like
phenomenon (Zhang et al., 2008), which has been associated
with behavioral hyperalgesia (Brenner et al., 2004).
Some independent support for considering P2X7 receptors as
potential targets in pain therapies is also provided by genetic
associations. Six of seven inbred mouse strains that showed
less than average allodynia also expressed P2X7 receptors
with a single nucleotide polymorphism resulting in the P451L
mutation (Sorge et al., 2012). Mouse P2X7[P451L] receptors
have impaired function as measured by ATP-evoked uptake of
YO-PRO-1 (a commonly used optical measure of pore dilation)
but not when measured as ATP-induced ionic current (Adriouch
et al., 2002; Young et al., 2006). Additionally, two other poly-
morphisms (H155Y, R270H) known to result in enhanced and
reduced P2X7 receptor function were found more often in
subjects reporting a higher and lower than average pain level,
respectively, following mastectomy (Sorge et al., 2012).
Demyelinating Disease
Inflammation is a component of the degeneration that occurs in
several nervous system disorders, and the involvement of P2X
receptors has been investigated in certain animal models of
disease. In mice, experimental autoimmune encephalitis (EAE)can be induced by immunization with myelin oligodendrocyte
glycoprotein. Studies on P2X7 deletion mice appear to be con-
tradictory. In the Pfizer mice, the clinical and pathological
features of EAE are more marked in ‘‘knockouts,’’ whereas in
the Glaxo mice the deficiency of the P2X7 receptor suppressed
the development of EAE (Sharp et al., 2008).
Spinal Cord Injury
Considerable interest was created by the report that blocking
P2X7 receptors improves functional recovery after spinal cord
injury in rats (Wang et al., 2004). The receptor antagonists used
(oxoATP and PPADS) are nonselective, and their actions cannot
be reliably attributed to P2X7 receptor blockade. The results
were later extended by using Brilliant Blue G (Cotrina and Neder-
gaard, 2009; Peng et al., 2009), which is a more selective blocker
of mouse and rat P2X7 receptors (Jiang et al., 2000). However,
a recent study failed to replicate these results (Marcillo et al.,
2012). Additional systematic approaches are clearly required,
using the highly selective P2X7 receptor antagonists that are
now available. A role for P2X4 receptors has also been sug-
gested. In mice with deleted P2X4 receptors, there was a
decrease in caspase-1 cleavage and IL-1b production at the
injury site, which is correlated both with diminished neutrophil
andmacrophage infiltration at the injury site, and improved func-
tional outcome (de Rivero Vaccari et al., 2012).
Stroke
Large amounts of ATP are released from damaged cells as
a result of ischemia, which may activate P2X7 receptors. This
provides the logic for considering blockade of P2X7 receptors
as a possible therapeutic regimen. Pretreatment with PPADS
improves recovery from experimental stroke in rats with perma-
nent middle cerebral artery occlusion (La¨mmer et al., 2011).
Treatment with brilliant Blue G beginning 30 min after middle
cerebral artery occlusion caused a 60% reduction in brain
damage measured three days later (Arbeloa et al., 2012). These
studies need to be extended to determine if P2X7 receptors are
valid targets in stroke and whether the relevant receptors are
located on astrocytes or neurons.
Summary and Future Opportunities
In this review, we have highlighted some of the recent literature
that sheds new light on how P2X receptors work and how they
mediate neuromodulation in diverse systems. Representing
a novel structural class of ion channels with several unique func-
tional properties, and mediating fascinating slow responses, the
physiology of ATP P2X receptors has challenged our precepts of
how a fast neurotransmitter-gated cation channel should look
and behave. New biophysics and biology has been discovered,
and many early biophysical and physiological insights have
been supported with high resolution crystal structures, optical
approaches and molecular genetics.
Based on the aforementioned latest breakthroughs, we
propose that P2X receptors have evolved to fulfill unique biolog-
ical functions and occupy signaling niches that are not readily
met by other fast neurotransmitter systems. Given that glia
constitute about half the cells in the brain, express multiple
ATP receptors and release ATP through a variety of mecha-
nisms, we suggest that a major facet of ATP and P2X receptor
biology is related to glia and their slow neuromodulatoryNeuron 76, October 4, 2012 ª2012 Elsevier Inc. 63
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tory capacity and largely unexplored potential, ATP acting via
P2X receptors is a physiologically important signal, particularly
for linking slow glial communications with fast neural microcircuit
computations.
For continued progress, it will be vital that we explore P2X
receptor functions with the best available tools. Luckily, many
P2X receptor knockout mice are now available and selective
antagonists are being discovered (Table 1). With the publication
of the P2X crystal structures, several classic biophysical ques-
tions have been answered and there can be little doubt the field
has moved into an exciting new era. We now await the structure
of a full length P2X receptor with its cytosolic domains, which will
allow us to relate the findings to the wealth of studies on receptor
function and gating. One would also like to know if the ATP
bound state represents the only open state or an intermediate
conformation of the permeation pathway. It will be important
to continue to use simple systems to explore ion channel
biophysics, but more nuanced cell biological issues such as traf-
ficking, protein-protein interactions and receptor regulation
should be performed in intact systems such as native cell lines,
primary cultures and in vivo to render the findings meaningful
in a physiological manner. Additionally, the generation of
a battery of P2X reporter micewill allow for the study of live tissue
specimens, thus ending our reliance on staining with antibodies
of limited selectivity and on dead tissue. Use of such reporter
mice is perhaps the only immediately obvious way to address
the issue of heterogeneous responses, because it would allow
researchers to record fromgenetically specified cell populations.
It also seems necessary to generate mouse lines expressing
tamoxifen inducible Cre recombinase under the P2X4 and
P2X7 receptor promoters because of their roles in pain, allowing
mechanistic experiments in vivo to commence, thus ending
correlative interpretations and aiding exploration of causation
in the spinal pain microcircuitry. Our improved knowledge of
ATP binding and gating in P2X receptors also presents itself as
an opportunity to design/reengineer P2X receptors to perform
specific tasks, such as chaperoning other proteins to the edges
of dendritic spines or to nerve terminals in the treatment of
synaptic diseases, or to provide known and desired fluxes in
specific domains of neurons that need them. It seems necessary
to evaluate if cross-inhibition between P2X receptors and other
ion channels has behavioral consequences, either physiologi-
cally or during disease states, and thus explore this neuromodu-
latory regulation. Similarly, we need to determine the proteome
of key P2X receptors to understand both physiology and
biophysics of these proteins: P2X4 and P2X7 receptors seem
to be a good place to start given their roles in pain.
The field of P2X receptor signaling holds great promise to treat
human diseases, which is an important remit and mandate of
publicly funded biological research. Recent exciting break-
throughs offer ample chances for national research agencies to
invest in an area with largely untapped clinical potential and
thus deliver on their promise to advance human therapeutics.
From this perspective, the entire field eagerly awaits the results
of ongoing clinical trials on the first generation of drugs targeting
P2X receptors to treat pain states, bladder dysfunction and
cough (Ford, 2012; Gum et al., 2012). There is huge unexplored64 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.potential to exploit ATP signaling for treating CNS disease.
We need to explore these possibilities from a grass roots level
and up.
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